Abstract
The ability of polymers to be degraded in physiological environments makes them interesting candidates for various medical applications. Degradation and metabolisation or excretion of polymeric implants can avoid a second surgery for the removal of an implant. Biodegradable materials can serve as a temporary substitute of the extracellular matrix or as matrix in controlled drug release systems, which both can be utilized in Regenerative Therapies.
This chapter gives an overview about polymeric materials established in clinical use such as polyesters, polyurethanes, polyanhydrides, or carbohydrates. It describes further their synthesis and exemplary applications such as surgical sutures. Finally the importance of a continuing development of novel materials for future applications is pointed out, since the number of potential applications in the medical field is expanding rapidly.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Barker SA, Young NM (1966) Isolation of hyaluronic acid by gel filtration on agarose. Carbohydr Res 2: 363–370.
Behl M, Lendlein A (2007) Actively moving polymers. Soft Matter 3: 58–67.
Bera S, Jedlinski Z (1993) Block segmented polymers - a new method of synthesis of copoly(amide-ester) ester polymer. J Polym Sci Pol Chem 31: 731–739.
Boas NF (1949) Isolation of hyaluronic acid from the cocks comb. J Biol Chem 181: 573–575.
Brannon-Peppas L (1997) Polymers in controlled drug delivery. Med Plast Biomat: 34.
Bucher JE, Slade WC (1909) The anhydrides of isophthalic and terephthalic acids. J Am Chem Soc 31: 1319–1321.
Cardy RH (1979) Carcinogenicity and chronic toxicity of 2,4-toluenediamine in f344 rats. J Natl Cancer Inst 62: 1107–1116.
Chabot F, et al. (1983) Configurational structures of lactic-acid stereocopolymers as determined by 13C-labeled 1H-NMR. Polymer 24: 53–59.
Crivello JV, et al. (1996) Ketene acetal monomers: Synthesis and characterization. J Polym Sci Pol Chem 34: 3091–3102.
Deasy PB, et al. (1989) Preparation and characterization of lactic glycolic acid polymers and copolymers. J Microencapsulation 6: 369–378.
Di Lullo GA, et al. (2002) Mapping the ligand-binding sites and disease-associated mutations on the most abundant protein in the human, type I collagen. J Biol Chem 277: 4223–4231.
Domb AJ, et al. (1994). In: Shalaby SW, (Ed.), Biomedical polymers. Hanser Publishers, Munich, 1994, pp. 17–32.
Feng YK, Guo JT (2009) Biodegradable polydepsipeptides. Int J Mol Sci 10: 589–615.
Friedlaender GE, et al. (2001) Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions : A prospective, randomized clinical trial comparing rhop-1 with fresh bone autograft. J Bone Joint Surg 83: S151.
Govender S, et al. (2002) Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures - a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg 84A: 2123–2134.
Grigat E, et al. (1998) Bak 1095 and bak 2195: Completely biodegradable synthetic thermoplastics. Polym Degrad Stab 59: 223–226.
Gunatillake P, et al. (2006) Recent developments in biodegradable synthetic polymers. Biotechnol Annu Rev 12: 301–47.
Guo K, Chu CC (2007) Synthesis, characterization, and biodegradation of copolymers of unsaturated and saturated poly(ester amide)s. J Polym Sci Pol Chem 45: 1595–1606.
Han MG, et al. (2008) Synthesis and degradation behavior of poly(ethyl cyanoacrylate). Polym Degrad Stab 93: 1243–1251.
Heller J, et al. (2002) Poly(ortho esters): Synthesis, characterization, properties and uses. Adv Drug Delivery Rev 54: 1015–1039.
Heller J, et al. (1992) Synthesis and characterization of a new family of poly(ortho ester)s. Macromolecules 25: 3362–3364.
Heller J, et al. (1983) Controlled release of contraceptive steroids from biodegradable poly(ortho esters). Contraceptive Delivery Systems 4: 43–53.
Heller J, et al. (1995) Poly(ortho esters) for the pulsed and continuous delivery of peptides and proteins. In: Lee VHL, et al., (Eds.), Trends and future perspectives in peptide and protein drug delivery. Harwood Academic Publ Gmbh, Chur, 1995, Vol. 4, pp. 39–56.
Hill JW, Carothers WH (1932) Studies of polymerization and ring formation. XIV. A linear superpolyanhydride and a cyclic dimeric anhydride from sebacic acid. J Am Chem Soc 54: 1569–1579
Hodde J (2006) Extracellular matrix as a bioactive material for soft tissue reconstruction. Anz Journal of Surgery 76: 1096–1100.
Hoffman AS (2002) Hydrogels for biomedical applications. Adv Drug Delivery Rev 54: 3–12.
Horton VL, et al. (1988) Comparison of bioabsorbable poly(ester-amide) monomers and polymers in vivo using radiolabeled homologs. In: Gebelijn CG, Dunn RL, (Eds.), Progress in biomedical polymers. Plenum Press, New York, 1988, pp. 263–282.
Jain JP, et al. (2005) Role of polyanhydrides as localized drug carriers. J Controlled Release 103: 541–563.
Konan S, Haddad FS (2009) A clinical review of bioabsorbable interference screws and their adverse effects in anterior cruciate ligament reconstruction surgery. Knee 16: 6–13.
Kricheldorf HR, Serra A (1985) Polylactones. 6. Influence of various metal-salts on the optical purity of poly(l-lactide). Polymer Bulletin 14: 497–502.
Kricheldorf HR, Stricker A (2000) Macrocycles. 13. Stannylenated glucose glycosides as cyclic initiators of epsilon-caprolactone and the synthesis of biodegradable networks. Macromolecules 33: 696–701.
Kulkarni A, et al. (2007) Hydrolytic degradation of poly(rac-lactide) and poly[(rac-lactide)-co-glycolide] at the air-water interface. Surf Interface Anal 39: 740–746.
Laurencin CT, et al. (1995). In: Hollinger JO, (Ed.), Biomedical applications of synthetic biodegradable polymers. CRC-Press, Boca Raton, 1995, pp. 59–101.
Leenslag JW, et al. (1984) Resorbable materials of poly(l-lactide). 5. Influence of secondary structure on the mechanical-properties and hydrolyzability of poly(L-lactide) fibers produced by a dry-spinning method. J Appl Polym Sci 29: 2829–2842.
Leenslag JW, Pennings AJ (1987) Synthesis of high-molecular-weight poly(L-lactide) initiated with tin 2-ethylhexanoate. Makromol Chem, Macromol Chem Phys 188: 1809–1814.
Lendlein A (1999) Polymere als Implantatwerkstoffe. Chem unserer Zeit 33: 279–295.
Lendlein A, Kelch S (2002) Shape-memory polymers. Angew Chem, Int Ed 41: 2034–2057.
Lendlein A, Langer R (2002) Biodegradable, elastic shape-memory polymers for potential biomedical applications. Science 296: 1673–1676.
Lendlein A, et al. (1998) Tissue-compatible multiblock copolymers for medical applications, controllable in degradation rate and mechanical properties. Macromol Chem Phys 199: 2785–2796.
Li LC, et al. (2002) Polyanhydride implant for antibiotic delivery - from the bench to the clinic. Adv Drug Delivery Rev 54: 963–986.
Li X, Jastri BR (2006) Biodegradable polymeric delivery systems. Design of controlled release drug delivery systems. McGraw-Hill, New York, 2006, pp. 271–304.
Little U, et al. (2009) Accelerated degradation behaviour of poly(epsilon-caprolactone) via melt blending with poly(aspartic acid-co-lactide) (pal). Polym Degrad Stab 94: 213–220.
Martinez MB, et al. (1997) Hydrolytic degradation of poly(ester amides) derived from carbohydrates. Macromolecules 30: 3197–3203.
Meek MF, Coert JH (2008) US Food and Drug Administration/Conformit Europe-approved absorbable nerve conduits for clinical repair of peripheral and cranial nerves. Annals of Plastic Surgery 60(4): 466–472.
Nair LS, Laurencin CT (2007) Biodegradable polymers as biomaterials. Prog Polym Sci 32: 762–798.
Ng SY, et al. (1997) Synthesis and erosion studies of self-catalyzed poly(ortho ester)s. Macromolecules 30: 770–772.
Nieuwenhuis J (1992) Synthesis of polylactides, polyglycolides and their copolymers. Clin Mater 10: 59–67.
Paredes N, et al. (1998) Synthesis and characterization of a family of biodegradable poly(ester amide)s derived from glycine. J Polym Sci Pol Chem 36: 1271–1282.
Peppas NA (Ed.) 1987. Hydrogels in medicine and pharmacy. CRC-Press, Boca Raton.
Piskin E (1995) Biodegradable polymers as biomaterials J Biomat Sci, Polym Ed 6: 775–795.
Purcell DB, et al. (2004) Bioabsorbable interference screws in acl reconstruction. Oper Tech Sports Med 12: 180–187.
Qiu Y, Park K (2001) Environment-sensitive hydrogels for drug delivery. Adv Drug Delivery Rev 53: 321–339.
Shalaby SW, Johnson A (1994) Biomedical polymers. Designed-to-degrade systems. In: Shalaby SW, (Ed.). Hanser Publishers, Munich, 1994, pp. 1–34.
Shih C, et al. (1993) Invivo and invitro release of ivermectin from poly(ortho ester) matrices. 1. Cross-linked matrix prepared from ketene acetal end-capped prepolymer. J Controlled Release 25: 155–162.
Spaans CJ, et al. (1998) High molecular weight polyurethanes and a polyurethane urea based on 1,4-butanediisocyanate. Polymer Bulletin 41: 131–138.
Spotnitz WD, Burks S (2008) Hemostats, sealants, and adhesives: Components of the surgical toolbox. Transfusion 48: 1502–1516.
Syzcher M (Ed.) 1999. Syzcher’s handbook of polyurethanes. CRC-Press, Boca Raton.
Tang RP, et al. (2009) Poly(ortho ester amides): Acid-labile temperature-responsive copolymers for potential biomedical applications. Biomacromolecules 10: 722–727.
The European Society for Biomaterials (1991) 2nd consensus conference on definitions in biomaterials 7–8th september. J Mater Sci: Mater Med 2: 62.
Tsuji H, et al. (2003) Surface hydrophilicity and enzymatic hydrolyzability of biodegradable polyesters: 1. Effects of alkaline treatment. Polym Int 52: 843–852.
Ueda H, Tabata Y (2003) Polyhydroxyalkanonate derivatives in current clinical applications and trials. Adv Drug Delivery Rev 55(4): 501–518.
Vaccaro AR, et al. (2002) Bone grafting alternatives in spinal surgery. Spine J 2: 206–15.
Vera M, et al. (2006) Microspheres from new biodegradable poly(ester amide)s with different ratios of L- and D-alanine for controlled drug delivery. J Microencapsulation 23: 686–697.
Vert M (1986) Biomedical polymers from chiral lactides and functional lactones - properties and applications. Makromol Chem, Macromol Symp 6: 109–122.
Vert M (1989) Bioresorbable polymers for temporary therapeutic applications. Angew Makromol Chem 166: 155–168.
Weigel T, et al. (2006) Design and preparation of polymeric scaffolds for tissue engineering. Expert Rev Med Devices 3: 835–851.
Wu XS (1995). In: D.L. Wise DJT, D.E. Altobelli, M.J. Yaszemski, D.J. Gresser and E.R. Schwartz, (Ed.), Encyclopaedic handbook of biomaterials and bioengineering. Marcel Decker, New York, 1995, pp. 1015–1054.
Xiong X, et al. (2007) Isolated nature-identical collagen, WO 2007/137827 A1.
Ye T, et al. (2008) Enhanced cell affinity of poly(l-lactide) film by immobilizing phosphonized chitosan. Appl Surf Sci 255: 446–448.
Acknowledgements
We would like to thank the Deutsche Forschungsgemeinschaft (DFG, SFB 760) and the Bundesministerium für Bildung und Forschung (BMBF) for supporting the interdisciplinary research in the field of tissue regeneration.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Netherlands
About this chapter
Cite this chapter
Schroeter, M., Wildemann, B., Lendlein, A. (2011). Biodegradable Materials. In: Steinhoff, G. (eds) Regenerative Medicine. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-9075-1_20
Download citation
DOI: https://doi.org/10.1007/978-90-481-9075-1_20
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-9074-4
Online ISBN: 978-90-481-9075-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)